241 related articles for article (PubMed ID: 16721009)
1. Peritoneal dialysis infections recommendations.
Piraino B
Contrib Nephrol; 2006; 150():181-186. PubMed ID: 16721009
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment.
Thodis E; Passadakis P; Ossareh S; Panagoutsos S; Vargemezis V; Oreopoulos DG
Int J Artif Organs; 2003 Aug; 26(8):698-714. PubMed ID: 14521167
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
[TBL] [Abstract][Full Text] [Related]
4. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK
Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796
[TBL] [Abstract][Full Text] [Related]
5. Peritonitis associated with exit site and tunnel infections.
Gupta B; Bernardini J; Piraino B
Am J Kidney Dis; 1996 Sep; 28(3):415-9. PubMed ID: 8804241
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
[TBL] [Abstract][Full Text] [Related]
7. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
[TBL] [Abstract][Full Text] [Related]
8. [Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report].
Qiao J; Lu LX; He YT; Men CC; Chu XX; Wu B; Zhao HP; Wang M
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):748-754. PubMed ID: 37534662
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
Chen SS; Sheth H; Piraino B; Bender F
Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
[TBL] [Abstract][Full Text] [Related]
11. Insights on peritoneal dialysis-related infections.
Piraino B
Contrib Nephrol; 2009; 163():161-168. PubMed ID: 19494610
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal infections.
Piraino B
Adv Ren Replace Ther; 2000 Oct; 7(4):280-8. PubMed ID: 11073560
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal catheter exit-site and tunnel infections.
Piraino B
Adv Ren Replace Ther; 1996 Jul; 3(3):222-7. PubMed ID: 8827201
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study).
Jassal SV; Lok CE;
Perit Dial Int; 2008; 28(1):67-72. PubMed ID: 18178950
[TBL] [Abstract][Full Text] [Related]
15. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients.
Casey M; Taylor J; Clinard P; Graham A; Mauck V; Spainhour L; Brown P; Burkart J
Perit Dial Int; 2000; 20(5):566-8. PubMed ID: 11117248
[No Abstract] [Full Text] [Related]
16. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
Mahaldar A; Weisz M; Kathuria P
Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
[TBL] [Abstract][Full Text] [Related]
17. Preventing peritoneal dialysis related infections.
Piraino B
Minerva Urol Nefrol; 2006 Jun; 58(2):161-9. PubMed ID: 16767069
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal Dialysis-Associated Peritonitis.
Szeto CC; Li PK
Clin J Am Soc Nephrol; 2019 Jul; 14(7):1100-1105. PubMed ID: 31068338
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients.
Sachar M; Shah A
Ther Apher Dial; 2022 Apr; 26(2):275-287. PubMed ID: 34435734
[TBL] [Abstract][Full Text] [Related]
20. A review of Staphylococcus aureus exit-site and tunnel infections in peritoneal dialysis patients.
Piraino B
Am J Kidney Dis; 1990 Aug; 16(2):89-95. PubMed ID: 2200261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
